Ancora Pharma strengthens scientific advisory board

Prior to Ancora Pharma, Siber worked as the vice president and chief scientific officer of Wyeth. Prior to his work at Wyeth Vaccines Research, Siber was associate professor

Idenix Pharma names new CEO

Before joining Idenix in 2007, Renaud worked as the senior vice president and chief financial officer of Keryx Biopharmaceuticals. Idenix Pharma lead director of the board of directors

Sanofi-aventis Q3 revenues rise

Sanofi-aventis has posted a net income of EUR1.66bn for the third quarter 2010, compared to EUR1.53bn for the comparable period in 2009. Operating income was EUR1.71bn, compared to

Amira Pharma commences AM152 Phase 1 study

Amira Pharma Clinical Development vice president Isabelle DeArmond said that they are excited to begin their journey exploring the therapeutic value of AM152, a potentially novel anti-fibrotic agent.

Astellas Pharma files lawsuit against Nycomed

Teva Pharma to take over Theramex from Merck Serono

Théramex offers a range of women’s health products sold in 50 countries worldwide. The company’s pipeline includes a new oral contraceptive based on natural estrogens, NOMAC/E2, which has

Stirling names new chief financial officer

Prior to joining Stirling, Kean has held positions as a tutor at the University of Technology in Sydney and as a senior researcher in fields including the Financial

Sunovion Pharma Latuda gets FDA nod

Sunovion Pharma said that Latuda is included in the atypical antipsychotic class of drugs. FDA Center for Drug Evaluation and Research Division of Psychiatry Products director Thomas Laughren

InterMune Q3 net revenues fall

InterMune has posted a net loss of $24.28m for the third quarter 2010, or $0.44 loss per diluted share, compared to net loss of $8.77m, or $0.19 loss

Emergent acquires Trubion Pharma

With this take over, Emergent gains access to multiple, advanced stage candidates in the key disease areas of oncology and autoimmunity as well as access to new and